• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E3A 泛素连接酶调控的亨廷顿蛋白片段的差异泛素化和降解。

Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.

机构信息

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322.

出版信息

Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5706-11. doi: 10.1073/pnas.1402215111. Epub 2014 Mar 31.

DOI:10.1073/pnas.1402215111
PMID:24706802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3992696/
Abstract

Ubiquitination of misfolded proteins, a common feature of many neurodegenerative diseases, is mediated by different lysine (K) residues in ubiquitin and alters the levels of toxic proteins. In Huntington disease, polyglutamine expansion causes N-terminal huntingtin (Htt) to misfold, inducing neurodegeneration. Here we report that shorter N-terminal Htt fragments are more stable than longer fragments and find differential ubiquitination via K63 of ubiquitin. Aging decreases proteasome-mediated Htt degradation, at the same time increasing K63-mediated ubiquitination and subsequent Htt aggregation in HD knock-in mice. The association of Htt with the K48-specific E3 ligase, Ube3a, is decreased in aged mouse brain. Overexpression of Ube3a in HD mouse brain reduces K63-mediated ubiquitination and Htt aggregation, enhancing its degradation via the K48 ubiquitin-proteasome system. Our findings suggest that aging-dependent Ube3a levels result in differential ubiquitination and degradation of Htt fragments, thereby contributing to the age-related neurotoxicity of mutant Htt.

摘要

泛素化的错误折叠的蛋白质,是许多神经退行性疾病的一个共同特征,由不同的赖氨酸(K)残基在泛素和改变的水平有毒蛋白介导。在亨廷顿病,多聚谷氨酰胺扩展导致 N 端亨廷顿(Htt)错折,诱导神经退行性变。在这里,我们报告说,较短的 N 端 Htt 片段比长片段更稳定,发现通过 K63 泛素的差异泛素化。老化降低蛋白酶体介导的 Htt 降解,同时增加 K63 介导的泛素化和随后的 Htt 聚集在 HD 敲入小鼠。与 K48 特异性 E3 连接酶,Ube3a 的 Htt 的协会在老年小鼠脑减少。在 HD 小鼠脑中的 Ube3a 的过表达减少 K63 介导的泛素化和 Htt 聚集,增强其通过 K48 泛素-蛋白酶体系统降解。我们的研究结果表明,年龄依赖性 Ube3a 水平导致 Htt 片段的差异泛素化和降解,从而有助于突变 Htt 的年龄相关的神经毒性。

相似文献

1
Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.E3A 泛素连接酶调控的亨廷顿蛋白片段的差异泛素化和降解。
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5706-11. doi: 10.1073/pnas.1402215111. Epub 2014 Mar 31.
2
Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.亨廷顿病突变蛋白的降解:蛋白酶体和分子伴侣的参与。
Mol Neurobiol. 2018 Oct;55(10):7652-7668. doi: 10.1007/s12035-018-0900-8. Epub 2018 Feb 12.
3
Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.泛素/蛋白酶体系统通过 FE65 调节突变型亨廷顿蛋白的降解。
Biochem J. 2012 May 1;443(3):681-9. doi: 10.1042/BJ20112175.
4
Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.E3 连接酶WWP1介导的非典型泛素化抑制蛋白酶体介导的突变型亨廷顿蛋白降解。
Brain Res. 2016 Jul 15;1643:103-12. doi: 10.1016/j.brainres.2016.03.027. Epub 2016 Apr 21.
5
Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.抑制泛素-蛋白酶体系统会导致毒性 N 端突变 huntingtin 片段的优先积累。
Hum Mol Genet. 2010 Jun 15;19(12):2445-55. doi: 10.1093/hmg/ddq127. Epub 2010 Mar 30.
6
Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation.肿瘤坏死因子受体相关因子 6(TRAF6)与亨廷顿蛋白结合,并促进其非典型泛素化,从而增强聚集体的形成。
J Biol Chem. 2011 Jul 15;286(28):25108-17. doi: 10.1074/jbc.M110.187591. Epub 2011 Mar 25.
7
Clearance of mutant huntingtin.清除突变型亨廷顿蛋白。
Autophagy. 2010 Jul;6(5):663-4. doi: 10.4161/auto.6.5.12336.
8
The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.去泛素化酶ataxin-3在亨廷顿病基因敲入小鼠模型中不调节疾病进展。
J Huntingtons Dis. 2013;2(2):201-15. doi: 10.3233/JHD-130058.
9
Ubiquitin-activating enzyme activity contributes to differential accumulation of mutant huntingtin in brain and peripheral tissues.泛素激活酶活性有助于突变型亨廷顿在大脑和外周组织中的差异积累。
J Neurosci. 2014 Jun 18;34(25):8411-22. doi: 10.1523/JNEUROSCI.0775-14.2014.
10
The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.亨廷顿蛋白和 HAP1 通过调节自噬体的动态平衡,而突变亨廷顿蛋白的表达会破坏这种调节,导致货物降解缺陷。
J Neurosci. 2014 Jan 22;34(4):1293-305. doi: 10.1523/JNEUROSCI.1870-13.2014.

引用本文的文献

1
AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington's Disease.人工智能助力亨廷顿舞蹈病可成药靶点及新疗法的转录组学发现
Brain Sci. 2025 Aug 14;15(8):865. doi: 10.3390/brainsci15080865.
2
Proteome solubility is differentially reshaped by thermal stress and regulators of ubiquitination.蛋白质组的溶解度因热应激和泛素化调节剂而发生不同程度的重塑。
J Biol Chem. 2025 Jul 24;301(9):110517. doi: 10.1016/j.jbc.2025.110517.
3
Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.神经系统中的泛素化:从分子机制到疾病影响
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05220-w.
4
Mutant THAP11 causes cerebellar neurodegeneration and triggers TREM2-mediated microglial activation in mice.突变型THAP11可导致小鼠小脑神经变性,并引发TREM2介导的小胶质细胞激活。
J Clin Invest. 2025 Jun 3;135(14). doi: 10.1172/JCI178349. eCollection 2025 Jul 15.
5
Huntingtin inclusion bodies have distinct immunophenotypes and ubiquitination profiles in the Huntington's disease human cerebral cortex.亨廷顿蛋白包涵体在亨廷顿病患者大脑皮层中具有不同的免疫表型和泛素化特征。
Sci Rep. 2025 May 3;15(1):15546. doi: 10.1038/s41598-025-00465-w.
6
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration.揭示泛素蛋白连接酶E3A在神经发育和神经退行性变中的作用
Int J Mol Sci. 2025 Mar 5;26(5):2304. doi: 10.3390/ijms26052304.
7
Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System.泛素-蛋白酶体介导的蛋白质降解与中枢神经系统疾病
Int J Mol Sci. 2025 Jan 24;26(3):966. doi: 10.3390/ijms26030966.
8
The ubiquitin-conjugating enzyme UBE2D maintains a youthful proteome and ensures protein quality control during aging by sustaining proteasome activity.泛素结合酶UBE2D维持年轻的蛋白质组,并通过维持蛋白酶体活性确保衰老过程中的蛋白质质量控制。
PLoS Biol. 2025 Jan 29;23(1):e3002998. doi: 10.1371/journal.pbio.3002998. eCollection 2025 Jan.
9
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.蛋白质相分离和聚集在神经退行性疾病中的病理性作用。
Int J Mol Sci. 2024 Sep 23;25(18):10187. doi: 10.3390/ijms251810187.
10
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.HAP40 调节亨廷顿病小鼠中突变型亨廷顿蛋白的聚集和毒性。
Cell Death Dis. 2024 May 14;15(5):337. doi: 10.1038/s41419-024-06716-4.

本文引用的文献

1
Multiple Aspects of Gene Dysregulation in Huntington's Disease.亨廷顿舞蹈症中基因失调的多个方面
Front Neurol. 2013 Oct 23;4:127. doi: 10.3389/fneur.2013.00127.
2
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.帕金森病痴呆:α-突触核蛋白、tau 和淀粉样β 病理学的汇聚。
Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.
3
Linear ubiquitination: a newly discovered regulator of cell signalling.线性泛素化:一种新发现的细胞信号调节因子。
Trends Biochem Sci. 2013 Feb;38(2):94-102. doi: 10.1016/j.tibs.2012.11.007. Epub 2013 Jan 17.
4
Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.泛素连接酶 Ube3a 的功能障碍可能与亨廷顿病小鼠模型中的突触病理生理学有关。
J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724. Epub 2012 Jul 11.
5
Suppression of protein aggregation by chaperone modification of high molecular weight complexes.通过伴侣分子修饰高分子量复合物来抑制蛋白质聚集。
Brain. 2012 Apr;135(Pt 4):1180-96. doi: 10.1093/brain/aws022. Epub 2012 Mar 6.
6
Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.泛素/蛋白酶体系统通过 FE65 调节突变型亨廷顿蛋白的降解。
Biochem J. 2012 May 1;443(3):681-9. doi: 10.1042/BJ20112175.
7
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.有毒的 Aβ 寡聚体与阿尔茨海默病:一个需要穿衣服的皇帝。
Nat Neurosci. 2012 Jan 29;15(3):349-57. doi: 10.1038/nn.3028.
8
Huntington's disease: from molecular pathogenesis to clinical treatment.亨廷顿病:从分子发病机制到临床治疗。
Lancet Neurol. 2011 Jan;10(1):83-98. doi: 10.1016/S1474-4422(10)70245-3.
9
Proteasomal dysfunction in aging and Huntington disease.衰老和亨廷顿病中的蛋白酶体功能障碍。
Neurobiol Dis. 2011 Jul;43(1):4-8. doi: 10.1016/j.nbd.2010.11.018. Epub 2010 Dec 8.
10
Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.突变型亨廷顿蛋白在 586 位氨基酸处的剪切影响体内 caspase-6 的激活。
J Neurosci. 2010 Nov 10;30(45):15019-29. doi: 10.1523/JNEUROSCI.2071-10.2010.